BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8751300)

  • 1. Large-scale production and properties of immunoaffinity-purified human activated protein C concentrate.
    Orthner CL; Ralston AH; Gee D; Kent R; Kolen B; McGriff JD; Drohan WN
    Vox Sang; 1995; 69(4):309-18. PubMed ID: 8751300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale production and properties of human plasma-derived activated Factor VII concentrate.
    Tomokiyo K; Yano H; Imamura M; Nakano Y; Nakagaki T; Ogata Y; Terano T; Miyamoto S; Funatsu A
    Vox Sang; 2003 Jan; 84(1):54-64. PubMed ID: 12542734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hemophilia A with a highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatography.
    Addiego JE; Gomperts E; Liu SL; Bailey P; Courter SG; Lee ML; Neslund GG; Kingdon HS; Griffith MJ
    Thromb Haemost; 1992 Jan; 67(1):19-27. PubMed ID: 1615478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
    Burnouf-Radosevich M; Burnouf T
    Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against human plasma protein C and their uses for immunoaffinity chromatography.
    Regnault V; Rivat C; Pfister M; Stoltz JF
    Thromb Res; 1991 Sep; 63(6):629-40. PubMed ID: 1780807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T; Michalski C; Goudemand M; Huart JJ
    Vox Sang; 1989; 57(4):225-32. PubMed ID: 2617959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands.
    Bangalore N; Drohan WN; Orthner CL
    Thromb Haemost; 1994 Sep; 72(3):465-74. PubMed ID: 7855799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of activated protein C by aprotinin and the use of the insolubilized inhibitor for its purification.
    Taby O; Chabbat J; Steinbuch M
    Thromb Res; 1990 Jul; 59(1):27-35. PubMed ID: 1697990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic purification and properties of a therapeutic human protein C concentrate.
    Radosevich M; Zhou FL; Huart JJ; Burnouf T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 790(1-2):199-207. PubMed ID: 12767332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of protein C from Cohn Fraction IV-1 by mini-antibody.
    Rezania S; Ahn DG; Kang KA
    Adv Exp Med Biol; 2007; 599():125-31. PubMed ID: 17727256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive and facile assay for the measurement of activated protein C activity levels in vivo.
    Orthner CL; Kolen B; Drohan WN
    Thromb Haemost; 1993 May; 69(5):441-7. PubMed ID: 8322267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood protein technological industrial developments as a mirror of fundamental studies bgy the Institute of Biochemistry of the Ukrainian National Academy of Sciences].
    Volkov GL; Andrianov SI; Horoshnykova TV; Borysevych OS; Gavryliuk OS
    Ukr Biokhim Zh (1999); 2000; 72(4-5):109-21. PubMed ID: 11200439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of functional endothelial protein C receptor in human plasma.
    Kurosawa S; Stearns-Kurosawa DJ; Hidari N; Esmon CT
    J Clin Invest; 1997 Jul; 100(2):411-8. PubMed ID: 9218519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of six human vitamin K-dependent proteins in a single chromatographic step using immunoaffinity columns.
    Jenny R; Church W; Odegaard B; Litwiller R; Mann K
    Prep Biochem; 1986; 16(3):227-45. PubMed ID: 3748998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C separation from human blood plasma derivatives using low cost chromatography.
    Wu H; Bruley DF
    Adv Exp Med Biol; 2003; 530():143-51. PubMed ID: 14562712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct detection of activated protein C in blood from human subjects.
    Gruber A; Griffin JH
    Blood; 1992 May; 79(9):2340-8. PubMed ID: 1571547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoaffinity purification of protein C by using conformation-specific monoclonal antibodies to protein C-calcium ion complex.
    Nakamura S; Sakata Y
    Biochim Biophys Acta; 1987 Aug; 925(2):85-93. PubMed ID: 3620498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gamma-carboxyglutamic acid (gamma) variant (gamma 6D, gamma 7D) of human activated protein C displays greatly reduced activity as an anticoagulant.
    Zhang L; Castellino FJ
    Biochemistry; 1990 Dec; 29(48):10828-34. PubMed ID: 2125495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects.
    Okajima K; Koga S; Kaji M; Inoue M; Nakagaki T; Funatsu A; Okabe H; Takatsuki K; Aoki N
    Thromb Haemost; 1990 Feb; 63(1):48-53. PubMed ID: 2140205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.
    Gale AJ; Sun X; Heeb MJ; Griffin JH
    Protein Sci; 1997 Jan; 6(1):132-40. PubMed ID: 9007985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.